Humira®, manufactured by AbbVie, is again at the top of the list and semaglutide (Ozempic® and Wegovy ... construction (4.9%), water services (5.1%) and medical gases (4%). Pharmacy projections ...

Novo Nordisk shares surged on the results of a new obesity-drug study Friday. The Danish pharmaceutical giant behind Ozempic ...

and medical gases (4%). Pharmacy projections are based on Vizient client purchases from Oct. 1, 2023, through Sept. 30, 2024. Non-pharmacy supply chain projections are based on a Vizient analysis of ...

Fact checked by Stella Osoba Weight loss drugs are considered an effective way to slim down. While there are health risks, ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Ozempic’s expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

In a Phase 2b trial, older patients taking Novo Nordisk’s Wegovy and Veru’s experimental drug, called enobosarm, lost on average 1.2% of lean mass after 16 weeks, compared with a 4.1% loss in ...

NOVO.B), which makes Ozempic and Wegovy, is now Europe's largest company by market capitalization, largely due to the popularity of the GLP-1 medications. (Even larger is U.S.-based Eli Lilly & Co ...

Independent pharmacy leaders have warned that draft GPhC guidance allows patients to “inappropriately access weight loss injections”, while representatives for the largest pharmacies have said that no ...

Clinics in Columbus, Cleveland, Dayton, and Cincinnati have lost their licenses to distribute dangerous drugs after the Ohio ...

In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...